Lilly Asia Ventures is a private equity general partner firm headquartered in Shanghai, China.
InventisBio, a China-based biotech company, raised $19m in Series B from OrbiMed Asia Partners and Lilly Asia Ventures.
TP Therapeutics, a San Diego-based clinical-stage biopharmaceutical company, raised $45m in Series C from Lilly Asia Ventures and others.
Betta Pharmaceuticals, a Chinese VC-backed drug developer, has completed a RMB720m domestic IPO.
Read more news concerning Lilly Asia Ventures
A sampling of Lilly Asia Ventures portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?